NxStage Medical
Financials
Estimates*
EUR | 2015 | 2016 | 2017 |
---|---|---|---|
R&D budget | 24.0m | 31.0m | 33.0m |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $6.0m | Series C | |
$15.9m | Series E | ||
N/A | N/A | IPO | |
$5.6m | Post IPO Equity | ||
$2.0b Valuation: $2.0b | Acquisition | ||
Total Funding | CAD29.9m |
Related Content
Recent News about NxStage Medical
EditNxStage Medical, Inc. specializes in providing innovative home hemodialysis solutions aimed at enhancing patient care and quality of life for individuals with chronic kidney disease. The company operates in the healthcare sector, focusing on renal replacement therapies. NxStage serves patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD), offering them the flexibility and convenience of home-based dialysis treatments. The company's core product, the NxStage System One, is designed to be user-friendly and portable, allowing patients to perform dialysis at home or on the go. This system is particularly beneficial for patients who require more frequent dialysis sessions, as it can be tailored to fit their individual needs and schedules.
NxStage's business model revolves around the sale and rental of its dialysis systems, along with the recurring revenue from the consumables and supplies required for each treatment session. The company also operates a limited number of dialysis clinics that serve as centers for innovation in care delivery models for ESRD patients. These clinics provide a controlled environment to test and refine new therapies and technologies before broader market introduction.
NxStage generates revenue through direct sales to patients, healthcare providers, and dialysis clinics, as well as through partnerships with other healthcare organizations. The company also offers support services, including training and education for patients and healthcare professionals, to ensure the effective use of its products.
Keywords: home hemodialysis, chronic kidney disease, ESRD, NxStage System One, renal replacement therapy, patient care, dialysis clinics, healthcare innovation, portable dialysis, medical devices.